Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02614170 · ClinicalTrials.gov registry record
A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Insulin in Healthy Individuals
A clinical trial, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 328
- Enrollment target
NCT02614170: Completed study, sponsored by Fujirebio Diagnostics.
NCT02614170 is a clinical trial that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 328 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02614170 has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 328 participants
- Enrollment target
Study Summary
The study objectives are described below: 1. Obtain matched serum, plasma \[(K2 EDTA, Sodium Heparin (NaH), Lithium Heparin (LiH)\] and urine specimens collected from a minimum of 50 healthy subjects. Specimens will be used to determine a reference range for C-peptide and insulin assays, used as an aid in the assessment of C-peptide and insulin in adults. 2. Obtain serum and urine specimens collected from a minimum of an additional 200 healthy subjects. Specimens will be used to determine a reference range for C-peptide and insulin assays, used as an aid in the assessment of C-peptide and insulin in adults. 3. To store any remaining specimens for use in future assay development and to evaluate as yet undetermined assays for the development of IVDs, including additional C-peptide or insulin assays.
Primary Outcome
250 healthy subjects
Interventions
- OTHER Prospective Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 328 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-06 |
What the finished NCT02614170 record still lists
NCT02614170 is an observational study that tracks outcomes without assigning an intervention. The registered 328 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Prospective Blood Draw is the first listed.
NCT02614170 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02614170 about?
NCT02614170 is a clinical study titled "A Prospective Collection of Peripheral Blood and Urine Specimens to Study C-peptide and Insulin in Healthy Individuals". The study objectives are described below: 1. Obtain matched serum, plasma \[(K2 EDTA, Sodium Heparin (NaH), Lithium Heparin (LiH)\] and urine specimens collected from a minimum of 50 healthy subjects. Specimens will be used to determine a reference range for C-peptide and insulin assays, used as an...
What is the current status of trial NCT02614170?
This trial is currently completed. The enrollment target is 328 participants. The study started on 2015-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02614170?
The interventions under investigation include: Prospective Blood Draw (OTHER).
Who is sponsoring clinical trial NCT02614170?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
- NCT05548413 · 328 participants · NA
Improving Medication Adherence Using Family-focused and Literacy-sensitive Strategies
- NCT06393725 · 328 participants · NA
Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia